Huons Co., Ltd. acquires stake in PanGen to accelerate biopharmaceutical development
Acquiring Company
Huons Group
Acquired Company
PanGen Biotech
Description
Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. The acquisition is aimed at expanding Huons' biopharmaceutical research and development expertise, as well as strengthening its contract development and manufacturing organization (CDMO) business. This strategic move is expected to enhance Huons' global competitiveness and lead to synergies between affiliates.
Other recent acquisitions in Biopharma and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie completes acquisition of Aliada Therapeutics to enhance neuroscience development (December 11, 2024)
- H.B. Fuller Company signs agreements to acquire Medifill Ltd. and GEM S.r.l. to expand its Medical Adhesive Technologies business (December 2, 2024)
- Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne (November 25, 2024)
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Celltrion acquires iQone Healthcare Switzerland to strengthen European expansion (November 14, 2024)
- AbbVie announces acquisition of Aliada Therapeutics, focusing on Alzheimer's disease and neuroscience pipeline (October 28, 2024)
Who to call at Huons Group, and when
When Huons Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Huons Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Huons Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Huons Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Huons Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PanGen Biotech?
PanGen Biotech was acquired by Huons Group, based in Seongnam-si. The deal was reported on November 7, 2024. Huons Group is a South Korean conglomerate focusing on the pharmaceutical and biopharmaceutical industries. The company aims to enhance its growth strategy through mergers and acquisitions. Huons Group is privately held and operates in Manufacturing.
When did Huons Group acquire PanGen Biotech?
Huons Group's acquisition of PanGen Biotech was reported on November 7, 2024. Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PanGen Biotech do?
PanGen Biotech Inc. is a company equipped with Good Manufacturing Practice (GMP) facilities for biopharmaceutical production. It is privately held, operating in Manufacturing, and is based in Durham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.